Literature DB >> 10556141

Pulmonary edema develops after recurrent obstructive apneas.

E C Fletcher1, M Proctor, J Yu, J Zhang, J J Guardiola, C Hornung, G Bao.   

Abstract

There are anecdotal reports of pulmonary edema after a night of recurrent obstructive apneas (OAs) in humans, but no data on lung water, gas exchange, filling pressure, or cardiac output (Q) exist in these patients. By clamping the endotracheal tube of eight intubated, anesthesized dogs, we created repetitive OAs of 45-s duration at 30-s intervals, for 8 h. Five additional dogs without apneas, but identically instrumented, were studied simultaneously, serving as nonapneic controls. Sa (O(2)) was measured by intraarterial catheter, pulmonary capillary wedge pressure (Pcw), continuous cardiac output (Q), and mixed venous oxygen saturation (Sv(O(2))) were measured by flotation catheter. Basal and hourly hemodynamics and blood gases (arterial and venous) under steady state respiration were measured. Venous admixture (Q S/Q T) was calculated by standard equations. Pa(O(2)) from the beginning to the end of the experiment fell from 89.6 to 82.8 mm Hg in apneic animals and from 92.2 to 85.5 mm Hg in controls. The Q S/Q T increased in both groups but more so in the apnea group (3.3 to 19.4%) than in nonapneic controls (3.1 to 7.9%). Neither Q nor Pcw changed significantly in either group. Lung wet/dry weight was 5.40 +/- 0.93 in apneic animals and 5.00 +/- 0.67 in controls. Light microscopy showed gross alveolar fluid in three apneic dogs, and electron microscopy showed interstitial fluid in two additional apneic dogs. One of the lung edema dogs expired of acute heart failure in the seventh hour of the experiment. Worsening of gas exchange and histology suggest that lung edema can result from recurrent OAs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556141     DOI: 10.1164/ajrccm.160.5.9810003

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

Review 1.  Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.

Authors:  Rami Khayat; Brian Patt; Don Hayes
Journal:  Heart Fail Rev       Date:  2008-09-20       Impact factor: 4.214

2.  Prevalence and treatment of breathing disorders during sleep in patients with heart failure.

Authors:  Shahrokh Javaheri; Laura Wexler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

Review 3.  Cardiopulmonary Interactions: Physiologic Basis and Clinical Applications.

Authors:  Michael R Pinsky
Journal:  Ann Am Thorac Soc       Date:  2018-02

Review 4.  Acute cardiopulmonary failure from sleep-disordered breathing.

Authors:  Gordon E Carr; Babak Mokhlesi; Brian K Gehlbach
Journal:  Chest       Date:  2012-03       Impact factor: 9.410

Review 5.  The link between obstructive sleep apnea and heart failure: underappreciated opportunity for treatment.

Authors:  Matthew T Naughton
Journal:  Curr Cardiol Rep       Date:  2005-05       Impact factor: 2.931

Review 6.  Functional hemodynamic monitoring.

Authors:  Michael R Pinsky
Journal:  Crit Care Clin       Date:  2015-01       Impact factor: 3.598

Review 7.  Heart failure and sleep disorders.

Authors:  Gianfranco Parati; Carolina Lombardi; Francesco Castagna; Paola Mattaliano; Pasquale Perrone Filardi; Piergiuseppe Agostoni
Journal:  Nat Rev Cardiol       Date:  2016-05-12       Impact factor: 32.419

Review 8.  Obesity in asthma: approaches to treatment.

Authors:  Shyamala Pradeepan; Garth Garrison; Anne E Dixon
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 9.  Causes and treatment of oedema in patients with heart failure.

Authors:  Andrew L Clark; John G F Cleland
Journal:  Nat Rev Cardiol       Date:  2013-01-15       Impact factor: 32.419

10.  The relationship of daytime hypoxemia and nocturnal hypoxia in obstructive sleep apnea syndrome.

Authors:  Francesco Fanfulla; Mario Grassi; Anna Eugenia Taurino; Nadia D'Artavilla Lupo; Rossella Trentin
Journal:  Sleep       Date:  2008-02       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.